OPKO HEALTH, INC.
OPKdata completeness 100%17 fiscal years on fileOPKO HEALTH, INC. earns about -8% on invested capital, but has diluted owners by 16% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $1.77B1 | $1B2 | $863.5M3 | $713.1M3 | $606.9M3 |
| Net income | −$30.1M4 | −$328.4M5 | −$188.9M6 | −$53.2M6 | −$225.7M6 |
| Operating cash flow | $38.3M7 | −$95.2M8 | −$28.2M9 | −$183.5M9 | −$178.5M9 |
| Capital expenditure | $32.2M10 | $24.6M11 | $16.3M12 | $25M12 | $12.3M12 |
| Free cash flow (derived) | $6.18M7 | −$119.8M8 | −$44.5M9 | −$208.5M9 | −$190.8M9 |
| Total debt | $205.3M13 | $267.3M14 | $9.77M15 | $877.4M16 | $690.2M16 |
| Cash & equivalents | $134.7M17 | $153.2M18 | $95.9M19 | $426.6M20 | $364.4M20 |
| Diluted shares | 648.1M | 719.1M | 751.8M | 694.0M | 751.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $16.88 of net worth that earned you −$3 and generated −$2.54 of cash last year, against $9.19 of debt.
It earned an average -8% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 16% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has risen 236% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001437749-24-006285 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005811 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-076596 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001437749-24-006285 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005811 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-076596 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001437749-24-006285 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005811 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-076596 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001437749-24-006285 (PaymentsToAcquireProductiveAssets)
- 10-K · period ending 2022-12-31 · accession 0001437749-25-005811 (PaymentsToAcquireProductiveAssets)
- 10-K · period ending 2023-12-31 · accession 0001193125-26-076596 (PaymentsToAcquireProductiveAssets)
- 10-K · period ending 2021-12-31 · accession 0000944809-23-000013 (LongTermDebt)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-006285 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-005811 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0001193125-26-076596 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0000944809-23-000013 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001437749-24-006285 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001437749-25-005811 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001193125-26-076596 (CashAndCashEquivalentsAtCarryingValue)